Sebastian Rademacher

Dr. Sebastian Rademacher

orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 August 2019 in Cold Spring Harbor Perspectives in Medicine
Verified
Journal Article
Closed access
PDF file
SRSebastian Rademacher
Sebastian Rademacher
BEBritta J. Eickholt
Britta J. Eickholt
Phosphatase and tensin homolog (PTEN) is a classical tumor suppressor that antagonizes phosphatidylinositol 3-phosphate kinase (PI3K)/AKT signaling. Although there is a strong association of PTEN germline mutations with cancer syndromes, they have also been described in a subset of patients with autism spectrum disorders with macrocephaly characterized by impairments in social interactions and communication, repetitive behavior and, occasionally, epilepsy. To investigate PTEN's role during neurodevelopment and its implication for autism, several conditional Pten knockout mouse models have been generated. These models are valuable tools to understand PTEN's spatiotemporal roles during neurodevelopment. In this review, we will highlight the anatomical and phenotypic results from animal studies and link them to cellular and molecular findings.

2 June 2015 in Frontiers in Neuroscience
Verified
Journal Article
Open access
PDF file
NHNiko Hensel
Niko Hensel
SRSebastian Rademacher
Sebastian Rademacher
Peter ClausPeter Claus
Peter Claus
ROCK inhibition has been largely applied as a strategy to treat neurodegenerative diseases (NDDs) and promising results have been obtained in the recent years. However, the underlying molecular and cellular mechanisms are not fully understood and different models have been proposed for neurodegenerative disorders. Here, we aim to review the current knowledge obtained for NDDs identifying common mechanisms as well as disease-specific models. In addition to the role of ROCK in different cell types such as neurons and microglia, we focus on the molecular signaling-pathways which mediate the beneficial effects of ROCK. Besides canonical ROCK signaling, modulation of neighboring pathways by non-canonical ROCK-crosstalks is a recurrent pattern in many NDD-model systems and has been suggested to mediate beneficial effects of ROCK-inhibition.

7 June 2017 in Liver Transplantation
Verified
Journal Article
Open access
PDF file
SRSebastian Rademacher
Sebastian Rademacher
DSDaniel Seehofer
Daniel Seehofer
DEDennis Eurich
Dennis Eurich
WSWenzel Schoening
Wenzel Schoening
RNRuth Neuhaus
Ruth Neuhaus
JPJohann Pratschke
Johann Pratschke
De novo malignancies (DNMs) are one of the leading causes of late mortality after liver transplantation (LT). We analyzed 1616 consecutive patients who underwent LT between 1988 and 2006 at our institution. All patients were prospectively observed over a study period of 28 years by our own outpatient clinic. Complete follow‐up data were available for 96% of patients, 3% were incomplete, and only 1% were lost to follow‐up. The median follow‐up of the patients was 14.1 years. Variables with possible prognostic impact on the development of DNMs were analyzed, as was the incidence of malignancies compared with the nontransplant population by using standardized incidence ratios. In total, 266 (16.5%) patients developed 322 DNMs of the following subgroups: hematological malignancies (n = 49), skin cancer (n = 83), and nonskin solid organ tumors (SOT; n = 190). The probability of developing any DNM within 10 and 25 years was 12.9% and 23.0%, respectively. The respective probability of developing SOT was 7.8% and 16.2%. Mean age at time of diagnosis of SOT was 57.4 years (range, 18.3‐81.1 years). In the multivariate analysis, an increased recipient age (hazard ratio [HR], 1.03; P < 0.001) and a history of smoking (HR, 1.92; P < 0.001) were significantly associated with development of SOT. Moreover, the development of SOT was significantly increased in cyclosporine A–treated compared with tacrolimus‐treated patients (HR, 1.53; P = 0.03). The present analysis shows a disproportionate increase of de novo SOT with an increasing follow‐up period. Increased age and a history of smoking are confirmed as major risk factors. Moreover, the importance of immunosuppression is highlighted. Liver Transplantation 23 1404–1414 2017 AASLD.

30 November 2012 in PLOS ONE
Verified
Journal Article
Open access
PDF file
DHDirk Hofreuter
Dirk Hofreuter
JMJuliane Mohr
Juliane Mohr
OWOlga Wensel
Olga Wensel
SRSebastian Rademacher
Sebastian Rademacher
KSKerstin Schreiber
Kerstin Schreiber
JGJorge E. Galán
Jorge E. Galán
Campylobacter jejuni is a major cause of food-borne disease in industrialized countries. Carbohydrate utilization by C. jejuni is severely restricted, and knowledge about which substrates fuel C. jejuni infection and growth is limited. Some amino acids have been shown to serve as carbon sources both in vitro and in vivo. In the present study we investigated the contribution of serine and proline catabolism to the in vitro and in vivo growth of C. jejuni 81-176. We confirmed that the serine transporter SdaC and the serine ammonia-lyase SdaA are required for serine utilization, and demonstrated that a predicted proline permease PutP and a bifunctional proline/delta-1-pyrroline-5-carboxylate dehydrogenase PutA are required for proline utilization by C. jejuni 81-176. C. jejuni 81-176 mutants unable to utilize serine were shown to be severely defective for colonization of the intestine and systemic tissues in a mouse model of infection. In contrast, C. jejuni 81-176 mutants unable to utilize proline were only defective for intestinal colonization. These results further emphasize the importance of amino acid utilization in C. jejuni colonization of various tissues.

1 March 2014 in Cellular Signalling
Verified
Journal Article
Closed access
NHNiko Hensel
Niko Hensel
ISInga Stockbrügger
Inga Stockbrügger
SRSebastian Rademacher
Sebastian Rademacher
NBNatasha Broughton
Natasha Broughton
HBHella Brinkmann
Hella Brinkmann
Peter ClausPeter Claus
Peter Claus

17 July 2017 in Human Molecular Genetics
Verified
Journal Article
Open access
PDF file
SRSebastian Rademacher
Sebastian Rademacher
BVBert M Verheijen
Bert M Verheijen
NHNiko Hensel
Niko Hensel
MPMiriam Peters
Miriam Peters
GBGamze Bora
Gamze Bora
Peter ClausPeter Claus
Peter Claus
Cytoskeletal rearrangement during axon growth is mediated by guidance receptors and their ligands which act either as repellent, attractant or both. Regulation of the actin cytoskeleton is disturbed in Spinal Muscular Atrophy (SMA), a devastating neurodegenerative disease affecting mainly motoneurons, but receptor-ligand interactions leading to the dysregulation causing SMA are poorly understood. In this study, we analysed the role of the guidance receptor PlexinD1 in SMA pathogenesis. We showed that PlexinD1 is cleaved by metalloproteases in SMA and that this cleavage switches its function from an attractant to repellent. Moreover, we found that the PlexinD1 cleavage product binds to actin rods, pathological aggregate-like structures which had so far been described for age-related neurodegenerative diseases. Our data suggest a novel disease mechanism for SMA involving formation of actin rods as a molecular sink for a cleaved PlexinD1 fragment leading to dysregulation of receptor signaling.